New study shows why insurers should share rebates with Medicare Part D beneficiaries on a mandatory basis
By Holly Campbell | February 14, 2019
New research by three Milliman actuaries explores the dynamics underlying the relationship between Medicare Part D plan premiums and sharing rebates directly with beneficiaries at the pharmacy...
Read More
PhRMA comments to administration on Medicare Part D proposed rule
By Juliet Johnson | January 25, 2019
Today, the Pharmaceutical Research and Manufacturers of America (PhRMA) submitted comments in response to the CMS proposed rule, “Modernizing Part D and Medicare Advantage to Lower Drug Prices and...
Read More
New research shows changes to the six protected classes would harm most vulnerable patients and are unnecessary
By Juliet Johnson | January 24, 2019
In Medicare Part D, the six protected classes policy protects vulnerable seniors and low-income beneficiaries with serious and complex health conditions, while also allowing Part D insurance plans...
Read More
Keep the Six Protected Classes, protected
By Juliet Johnson | January 22, 2019
Medicare Part D has been successfully providing seniors with comprehensive drug coverage for more than a decade, and one of the cornerstones of the program has been to ensure the sickest and most...
Read More
Experts agree: the Bipartisan Budget Act changes to Medicare Part D jeopardize the program
By Juliet Johnson | September 24, 2018
The changes made to Part D in the Bipartisan Budget Act (BBA) that passed in February threaten the program’s successful competitive structure. While these changes closed the donut hole a year...
Read More
What if a couple of small fixes could protect seniors in the donut hole and save them money on out-of-pocket costs?
By Juliet Johnson | September 13, 2018
Right now, Congress has the opportunity to make two small fixes that will protect seniors in the Medicare Part D donut hole and save them money on out-of-pocket costs for their medicines. These...
Read More
PhRMA submission to HHS on blueprint to lower drug prices and reduce out-of-pocket costs
By Holly Campbell | July 16, 2018
Today, PhRMA submitted comprehensive comments to the Department of Health and Human Services (HHS) request for information (RFI), HHS Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs....
Read More
Pass-through rebates do not violate non-interference clause but they do increase savings for seniors
By Jim C. Stansel | July 2, 2018
For more than a decade, Medicare Part D has successfully provided seniors with comprehensive prescription drug coverage. Key to its success is a unique, market-based structure of private-sector...
Read More
Medicare Part D cliff ahead
By Juliet Johnson | June 21, 2018
Medicare Part D has been providing seniors with access to prescription drug coverage that meets their needs for more than a decade. Today, more than 42 million people are enrolled in Part D and 90...
Read More
Part D cliff looms for seniors, as program stability could be in jeopardy
By Juliet Johnson | June 18, 2018
For more than a decade, Medicare Part D has successfully provided seniors comprehensive prescription drug coverage that meets their needs, while its market-based structure has kept overall program...
Read More
Medicare Monday (100)
340B Spotlight (37)
Cost & Consequence (0)
